IMUNON ($IMNN) posted quarterly earnings results for Q1 2026 on Tuesday, May 12th. The company reported earnings of -$0.84 per share, beating estimates of -$1.13 by $0.29. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $IMNN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMUNON Hedge Fund Activity
We have seen 8 institutional investors add shares of IMUNON stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 266,886 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,016,835
- VANGUARD GROUP INC added 13,751 shares (+59.0%) to their portfolio in Q4 2025, for an estimated $52,391
- DRW SECURITIES, LLC added 3,803 shares (+6.9%) to their portfolio in Q4 2025, for an estimated $14,489
- MORGAN STANLEY removed 1,545 shares (-34.3%) from their portfolio in Q4 2025, for an estimated $5,886
- GEODE CAPITAL MANAGEMENT, LLC added 1,410 shares (+7.1%) to their portfolio in Q4 2025, for an estimated $5,372
- UBS GROUP AG removed 1,022 shares (-64.0%) from their portfolio in Q1 2026, for an estimated $3,004
- CITIGROUP INC removed 305 shares (-99.7%) from their portfolio in Q4 2025, for an estimated $1,162
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
